← Back to Patent Explorer
US4033816A Expired / Lapsed US ⏱️ 0.0 years remaining

Process for inhibiting platelet aggregation

Assignee: Pharmacia and Upjohn Co
•
Filing: 1974-10-15
•
Granted: 1977-07-05
•
Expires: 1994-10-15
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A process for inhibiting platelet aggregation by the addition of a member selected from the group consisting of a compound of the formula:

Inventors

  • 👤 Neel C. Sekhar

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-04 12:00
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/185; A61K31/19

Claims Analysis

Total Claims: 4
Claim 1
Independent Claim 102 words
A process for inhibiting platelet aggregation in vitro comprising the addition of an effective amount for inhibiting platelet aggregation of a compound of the formula: ##SPC2## wherein Y is lower alkyl of 1 to 8 carbon atoms, cyclopropyl, ethinyl, --CF 3 , --F, --Cl, --OCH 3 , --OCH 2 OCH 3 , --SCH 3 , --SCHF 2 , --SCH 2 OCH 3 , acetyl; R 1 and R 2 are H, CH 3 , CHF 2 , or taken together are =CH 2 or =CF 2 ; and X is hydrogen, or a pharmacologically acceptable cation, to whole blood or platelet-rich concentrates.
Claim 2
Dependent Claim 102 words
A process for inhibiting platelet aggregation in vitro comprising the addition of an effective amount for inhibiting platelet aggregation of a compound of the formula: ##SPC2## wherein Y is lower alkyl of 1 to 8 carbon atoms, cyclopropyl, ethinyl, --CF 3 , --F, --Cl, --OCH 3 , --OCH 2 OCH 3 , --SCH 3 , --SCHF 2 , --SCH 2 OCH 3 , acetyl; R 1 and R 2 are H, CH 3 , CHF 2 , or taken together are =CH 2 or =CF 2 ; and X is hydrogen, or a pharmacologically acceptable cation, to whole blood or platelet-rich concentrates.
Claim 3
Dependent Claim 24 words
The process of claim 1 wherein the amount of the compound added is from about 0.01 to 50 micrograms per ml. of whole blood.
Claim 4
Dependent Claim 12 words
The process of claim 1 wherein the compound added is 2-(6-methoxy-2-naphthyl)propionic acid.

References Cited (Backward Citations)

US3686183A Cited
US3663713A Cited
US3686238A Cited
US3663584A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1980-07-04 1981-01-03 1981-07-05 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1984-07-04 1985-01-03 1985-07-05 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1988-07-04 1989-01-03 1989-07-05 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag